BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao C, Bhattarai P, Chen M, Zhang N, Hameed S, Yue X, Dai Z. Amphiphilic Drug Conjugates as Nanomedicines for Combined Cancer Therapy. Bioconjugate Chem 2018;29:3967-81. [DOI: 10.1021/acs.bioconjchem.8b00692] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Saindane D, Bhattacharya S, Shah R, Prajapati BG. The recent development of topical nanoparticles for annihilating skin cancer. All Life 2022;15:843-869. [DOI: 10.1080/26895293.2022.2103592] [Reference Citation Analysis]
2 Hawthorne D, Pannala A, Sandeman S, Lloyd A. Sustained and targeted delivery of hydrophilic drug compounds: A review of existing and novel technologies from bench to bedside. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103936] [Reference Citation Analysis]
3 Wang J, Rui X, Jin Z, Leng X, Chen Z, Parvinzadeh Gashti M. Self-Delivering Supramolecular Nanofiber Based on Peptide-Rhein Conjugate. Journal of Nanomaterials 2022;2022:1-7. [DOI: 10.1155/2022/6880220] [Reference Citation Analysis]
4 Shi Z, Liu J, Tian L, Li J, Gao Y, Xing Y, Yan W, Hua C, Xie X, Liu C, Liang C. Insights into stimuli-responsive diselenide bonds utilized in drug delivery systems for cancer therapy. Biomed Pharmacother 2022;155:113707. [PMID: 36122520 DOI: 10.1016/j.biopha.2022.113707] [Reference Citation Analysis]
5 Sun Y, Fry CM, Shieh A, Cai X, Reardon TJ, Parquette JR. Self-assembly of a 5-fluorouracil and camptothecin dual drug dipeptide conjugate. Org Biomol Chem 2022. [PMID: 35734894 DOI: 10.1039/d2ob00762b] [Reference Citation Analysis]
6 Yang L, Li J, Guan Z, Zhang J, Wang X, Tang R. Carrier-free prodrug nanoparticles based on lonidamine and cisplatin for synergistic treatment of breast cancer. J Biomater Appl 2022;:8853282221107951. [PMID: 35689328 DOI: 10.1177/08853282221107951] [Reference Citation Analysis]
7 Fu Y, Bian X, Li P, Huang Y, Li C. Carrier-Free Nanomedicine for Cancer Immunotherapy. J Biomed Nanotechnol 2022;18:939-56. [PMID: 35854464 DOI: 10.1166/jbn.2022.3315] [Reference Citation Analysis]
8 Luo J, Zhang S, Zhu P, Liu W, Du J. Fabrication of pH/Redox Dual-Responsive Mixed Polyprodrug Micelles for Improving Cancer Chemotherapy. Front Pharmacol 2022;12:802785. [DOI: 10.3389/fphar.2021.802785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liang X, Chen M, Bhattarai P, Hameed S, Tang Y, Dai Z. Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles. ACS Nano 2021;15:20164-80. [PMID: 34898184 DOI: 10.1021/acsnano.1c08108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
10 Lu D, Chen M, Yu L, Chen Z, Guo H, Zhang Y, Han Z, Xu T, Wang H, Zhou X, Zhou Z, Teng G. Smart-Polypeptide-Coated Mesoporous Fe3O4 Nanoparticles: Non-Interventional Target-Embolization/Thermal Ablation and Multimodal Imaging Combination Theranostics for Solid Tumors. Nano Lett 2021;21:10267-78. [PMID: 34878286 DOI: 10.1021/acs.nanolett.1c03340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gao P, Zheng T, Cui B, Liu X, Pan W, Li N, Tang B. Reversing tumor multidrug resistance with a catalytically active covalent organic framework. Chem Commun (Camb) 2021;57:13309-12. [PMID: 34812448 DOI: 10.1039/d1cc04414a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 He W, Du Y, Li C, Wang J, Wang Y, Dogovski C, Hu R, Tao Z, Yao C, Li X. Dimeric artesunate-choline conjugate micelles coated with hyaluronic acid as a stable, safe and potent alternative anti-malarial injection of artesunate. Int J Pharm 2021;609:121138. [PMID: 34592395 DOI: 10.1016/j.ijpharm.2021.121138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zafar A, Hasan M, Tariq T, Dai Z. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies. Bioconjug Chem 2021. [PMID: 34793138 DOI: 10.1021/acs.bioconjchem.1c00437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kanwal S, Naveed M, Arshad A, Arshad A, Firdous F, Faisal A, Yameen B. Reduction-Sensitive Dextran-Paclitaxel Polymer-Drug Conjugate: Synthesis, Self-Assembly into Nanoparticles, and In Vitro Anticancer Efficacy. Bioconjug Chem 2021. [PMID: 34762796 DOI: 10.1021/acs.bioconjchem.1c00492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
15 Yang L, Xu J, Xie Z, Song F, Wang X, Tang R. Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo. Asian Journal of Pharmaceutical Sciences 2021;16:762-71. [DOI: 10.1016/j.ajps.2021.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
16 Cheng X, Li D, Xu J, Wei B, Fang Q, Yang L, Xue Y, Wang X, Tang R. Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis. Acta Pharm Sin B 2021;11:3595-607. [PMID: 34900539 DOI: 10.1016/j.apsb.2021.03.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Li G, Sun B, Li Y, Luo C, He Z, Sun J. Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery. Small 2021;:e2101460. [PMID: 34342126 DOI: 10.1002/smll.202101460] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
18 Tagde P, Tagde P, Tagde S, Bhattacharya T, Garg V, Akter R, Rahman MH, Najda A, Albadrani GM, Sayed AA, Akhtar MF, Saleem A, Altyar AE, Kaushik D, Abdel-Daim MM. Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme. Biomed Pharmacother 2021;141:111928. [PMID: 34323701 DOI: 10.1016/j.biopha.2021.111928] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
19 Xu Y, Liu R, Dai Z. Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing. Nanoscale 2020;12:21001-14. [PMID: 33078813 DOI: 10.1039/d0nr05452f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
20 Wang F, Li M, Lin C, Jin S, Li H, Lu Y, Wang H, Wang H, Wang X. Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity. Bioorg Med Chem 2021;39:116131. [PMID: 33852975 DOI: 10.1016/j.bmc.2021.116131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yang H, Liu R, Xu Y, Qian L, Dai Z. Photosensitizer Nanoparticles Boost Photodynamic Therapy for Pancreatic Cancer Treatment. Nanomicro Lett 2021;13:35. [PMID: 34138222 DOI: 10.1007/s40820-020-00561-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
22 Sahu BP, Biswas N, Das MK. Multifunctional nanotheranostics for cancer diagnosis and treatments. Multifunctional Theranostic Nanomedicines in Cancer 2021. [DOI: 10.1016/b978-0-12-821712-2.00008-6] [Reference Citation Analysis]
23 Xu J, Fang Q, Yang L, Gao J, Xue Y, Wang X, Tang R. pH-sensitive deoxycholic acid dimer for improving doxorubicin delivery and antitumor activity in vivso. Colloids and Surfaces B: Biointerfaces 2020;196:111319. [DOI: 10.1016/j.colsurfb.2020.111319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Karaosmanoglu S, Zhou M, Shi B, Zhang X, Williams GR, Chen X. Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release 2021;329:805-32. [PMID: 33045313 DOI: 10.1016/j.jconrel.2020.10.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
25 Deng Z, Liu S. Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles. Journal of Controlled Release 2020;326:276-96. [DOI: 10.1016/j.jconrel.2020.07.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
26 Li Y, Zhou Y, Yue X, Dai Z. Cyanine conjugates in cancer theranostics. Bioact Mater 2021;6:794-809. [PMID: 33024900 DOI: 10.1016/j.bioactmat.2020.09.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]
27 Preta G. New Insights Into Targeting Membrane Lipids for Cancer Therapy. Front Cell Dev Biol 2020;8:571237. [PMID: 32984352 DOI: 10.3389/fcell.2020.571237] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
28 Li Y, Chen Y, Huang Y, Wu W, Liu Y, Zhang J, Huang M, Gou M. Kinetic stability-driven cytotoxicity of small-molecule prodrug nanoassemblies. J Mater Chem B 2019;7:5563-72. [PMID: 31465067 DOI: 10.1039/c9tb01270b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
29 Li S, Shan X, Wang Y, Chen Q, Sun J, He Z, Sun B, Luo C. Dimeric prodrug-based nanomedicines for cancer therapy. J Control Release 2020;326:510-22. [PMID: 32721523 DOI: 10.1016/j.jconrel.2020.07.036] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 20.5] [Reference Citation Analysis]
30 Liu J, Cao C. Evaluation of a GSH-targeting prodrug via a sulfonamide-induced "integrative" platform for selective cancer therapy. Analyst 2020;145:4901-5. [PMID: 32478783 DOI: 10.1039/d0an00627k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liu L, Bao Y, Zhang Y, Xiao C, Chen L. Acid-responsive dextran-based therapeutic nanoplatforms for photodynamic-chemotherapy against multidrug resistance. International Journal of Biological Macromolecules 2020;155:233-40. [DOI: 10.1016/j.ijbiomac.2020.03.197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
32 Wang W, Fan J, Zhu G, Wang J, Qian Y, Li H, Ju J, Shan L. Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy. Int J Nanomedicine 2020;15:2921-33. [PMID: 32425524 DOI: 10.2147/IJN.S247443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Mo S, Zhang X, Hameed S, Zhou Y, Dai Z. Glutathione-responsive disassembly of disulfide dicyanine for tumor imaging with reduction in background signal intensity. Theranostics 2020;10:2130-40. [PMID: 32104501 DOI: 10.7150/thno.39673] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
34 Gabdrakhmanov DR, Vasilieva EA, Voronin MA, Kuznetsova DA, Valeeva FG, Mirgorodskaya AB, Lukashenko SS, Zakharov VM, Mukhitov AR, Faizullin DA, Salnikov VV, Syakaev VV, Latypov SK, Zuev YF, Zakharova LY. Soft Nanocontainers Based on Hydroxyethylated Geminis: Role of Spacer in Self-Assembling, Solubilization, and Complexation with Oligonucleotide. J Phys Chem C 2020;124:2178-92. [DOI: 10.1021/acs.jpcc.9b10079] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
35 Sahu BP, Biswas N, Das MK. Multifunctional Nanoscale Particles for Theranostic Application in Healthcare. Nano Medicine and Nano Safety 2020. [DOI: 10.1007/978-981-15-6255-6_14] [Reference Citation Analysis]
36 Zhou Y, Wang M, Dai Z. The molecular design of and challenges relating to sensitizers for cancer sonodynamic therapy. Mater Chem Front 2020;4:2223-34. [DOI: 10.1039/d0qm00232a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
37 Hameed S, Zhang M, Bhattarai P, Mustafa G, Dai Z. Enhancing cancer therapeutic efficacy through ultrasound‐mediated micro‐to‐nano conversion. WIREs Nanomed Nanobiotechnol 2020;12. [DOI: 10.1002/wnan.1604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Hou M, Li S, Xu Z, Li B. A Reduction‐responsive Amphiphilic Methotrexate‐Podophyllotoxin Conjugate for Targeted Chemotherapy. Chem Asian J 2019;14:3840-4. [DOI: 10.1002/asia.201901070] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
39 Wu D, Chen Y, Wen S, Wen Y, Wang R, Zhang Q, Qin G, Yi H, Wu M, Lu L, Tao X, Deng X. Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells. Nanoscale Res Lett 2019;14:314. [PMID: 31520223 DOI: 10.1186/s11671-019-3146-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
40 Chen M, Liang X, Dai Z. Manganese(iii)-chelated porphyrin microbubbles for enhanced ultrasound/MR bimodal tumor imaging through ultrasound-mediated micro-to-nano conversion. Nanoscale 2019;11:10178-82. [PMID: 31111845 DOI: 10.1039/c9nr01373c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
41 Xue X, Lindstrom A, Li Y. Porphyrin-Based Nanomedicines for Cancer Treatment. Bioconjug Chem 2019;30:1585-603. [PMID: 31023011 DOI: 10.1021/acs.bioconjchem.9b00231] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 25.7] [Reference Citation Analysis]
42 Mctaggart M, Malardier-jugroot C. Nanomedicine and Drug Delivery Systems in Overcoming Resistance to Targeted Therapy. Resistance to Targeted Anti-Cancer Therapeutics 2019. [DOI: 10.1007/978-3-030-21477-7_10] [Reference Citation Analysis]